Stay updated on PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.

Latest updates to the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, Revision: v3.6.5, was added to the page history and the previous Revision: v3.6.4 entry was removed, reflecting an update to the page's revision history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry, v3.6.4, was added to the record history, replacing the previous v3.6.3 entry and indicating an updated version of the study record.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed.SummaryDifference0.1%

- Check44 days agoChange Detected- The study record history now includes a new revision entry Revision: v3.6.2 and removes the older Revision: v3.6.0, updating the visible version history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study history now shows recruitment has ceased (no longer looking for participants) and a new revision entry v3.6.0 was added, replacing the previous revision v3.5.5 in the history.SummaryDifference0.5%

- Check65 days agoChange DetectedA new release revision v3.5.5 was added to the study history, replacing the previous v3.5.4.SummaryDifference0.1%

Stay in the know with updates to PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.